Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment begins in phase II study of Stemedica's itMSCs in patients with COVID-19

Aug. 6, 2021

Aptahem reports positive preliminary results from GLP studies of Apta-1

Aug. 6, 2021

New thyroid hormone receptor agonists divulged by Eccogene

Aug. 6, 2021

Hisun Accuray Therapeutics, Zhejiang Hisun Pharmaceutical present SHP-2 inhibitors

Aug. 6, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent cereblon ligands

Aug. 6, 2021

Suzhou Zelgen Biosciences discovers G12C mutant GTPase KRAS inhibitors

Aug. 6, 2021

Enanta nominates EDP-235 as clinical candidate for the treatment of COVID-19

Aug. 6, 2021

Syros enters clinical supply agreement with Roche to evaluate SY-5609 as part of INTRINSIC study

Aug. 6, 2021

Positive phase II data published from GENETIC-AF study of bucindolol in patients with heart failure

Aug. 6, 2021

KIR3DL3-HHLA2 pathway could be targeted for cancer immunotherapy

Aug. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026